Artificial intelligence (AI)-based risk stratification systems in upper gastrointestinal bleeding (UGIB) outperform existing risk scores, but successful implementation of such systems into practice requires acceptance and trust of the technology by clinicians…
Recurrent gastrointestinal bleeding (GIB) occurs in up to 20% of patients hospitalized with GIB and is a major cause of morbidity and mortality. Early identification of recurrent bleeding may improve patient management and outcomes…
Early identification of overt signs of GIB (melena, hematochezia, hematemesis) in hospitalized patients may enable expedited evaluation for inpatient endoscopy…